CNL’S CNRI-H Program Continues Strong Growth Thanks to New Projects With Repare Therapeutics and Defence Therapeutics
Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program CHALK RIVER, Ontario, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s …